Directory
>
Gwen Wilmes
Gwen Wilmes
Vice President, Analytical Development | Obsidian Therapeutics
Somerville, Massachusetts, United States
Gwen Wilmes
Summary
Gwen Wilmes is a highly accomplished Vice President of Analytical Development at Obsidian Therapeutics, with a Ph.D. in Molecular Biology from MIT. With extensive experience in assay development and biochemistry, Gwen has led teams in fast-paced environments, driving significant advancements in gene therapy and immunoassays. Her career spans various roles in prestigious organizations, showcasing her ability to manage large collaborations and foster scientific innovation. Gwen's strategic leadership has been pivotal in supporting clinical products and navigating complex regulatory landscapes. She has a proven track record in building analytical labs and developing cutting-edge technologies in the biotech sector. Outside her professional achievements, she is passionate about mentoring the next generation of scientists and promoting diversity in STEM fields.
Gwen Wilmes
Work Experience
Vice President, Analytical Development at
Obsidian Therapeutics
July 2022 - Present
Sr. Director, Analytical Development at
Obsidian Therapeutics
April 2020 - August 2022
Director, Process Analytical Development at
Editas Medicine
May 2017 - April 2020
Director, Analytical Development at
Dimension Therapeutics, Inc.
August 2014 - April 2017
Director of Molecular Technologies at
Excelimmune, Inc.
December 2009 - August 2014
Postdoctoral Fellow in Christine Guthrie's lab at
University of California, San Francisco
January 2004 - November 2009
Gwen Wilmes
Education
Massachusetts Institute of Technology, Ph.D.
January 1997 - January 2003
Amherst College, B.A.
January 1993 - January 1997
Frequently Asked Questions about Gwen Wilmes
What is Gwen Wilmes email address?
Gwen Wilmes's primary email address is *******@obsidiantx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Gwen Wilmes work for?
Gwen Wilmes is a Vice President, Analytical Development at Obsidian Therapeutics, a company specializing in Commercial physical research.
Where Gwen Wilmes graduated from?
Gwen Wilmes holds a degree in Biology from Massachusetts Institute of Technology.
How can I directly contact Gwen Wilmes?
To contact Gwen Wilmes directly, you can use the email address *******@obsidiantx.com. Complete contact information is available upon registration with Muraena.
Who is Gwen Wilmes?
Gwen Wilmes is a highly accomplished Vice President of Analytical Development at Obsidian Therapeutics, with a Ph.D. in Molecular Biology from MIT. With extensive experience in assay development and biochemistry, Gwen has led teams in fast-paced environments, driving significant advancements in gene therapy and immunoassays. Her career spans various roles in prestigious organizations, showcasing her ability to manage large collaborations and foster scientific innovation. Gwen's strategic leadership has been pivotal in supporting clinical products and navigating complex regulatory landscapes. She has a proven track record in building analytical labs and developing cutting-edge technologies in the biotech sector. Outside her professional achievements, she is passionate about mentoring the next generation of scientists and promoting diversity in STEM fields.
Gwen`s contact details
*******@obsidiantx.com
Colleagues
Vice President Regulatory Affairs
Vice President, Head of Cell Therapy
Vice President of IT and Facilities
Vice President Clinical Sciences
Vice President - Process Development and Manufacturing
Vice President, Head of Intellectual Property
Chief People Officer
Chief Executive Officer
Vice President, Clinical Operations & Translational Early Clinical Development